Longitudinal virological outcomes and factors associated with virological failure in behaviorally HIV-infected young adults on combination antiretroviral treatment in the Netherlands, 2000 to 2015.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 9 8 2019
pubmed: 9 8 2019
medline: 4 9 2019
Statut: ppublish

Résumé

Achieving and maintaining viral suppression in young adults (18-24 years) living with HIV is challenging. Overall HIV viral suppression rates are lower in young as compared to older adults. Longitudinal data provide valuable insight on dynamics of viral suppression and variables of potential influence on HIV virological failure (VF), but is scarce in young adults living with HIV on combination antiretroviral therapy (cART). We evaluated longitudinal virological outcomes of behaviorally young adults (18-24 years) living with HIV in the Netherlands over a period of 15 years.We analyzed data from the Dutch national HIV database of 816 young adults living with HIV on cART in the Netherlands from 2000 to 2015. VF was defined as 2 consecutive detectable plasma HIV-1 viral load (VL) measurements > 200 copies/ml. Generalized linear mixed model analyses were used to assess HIV VF over time and identify risk factors associated with VF.VF during the study follow-up occurred at least once in 26% of cases. The probability of experiencing VF decreased over the study period per calendar year (OR 0.78, 95% confidence interval [CI];0.72; 0.85). Factors significantly associated with VF were being infected through heterosexual contact (OR 5.20, CI 1.39;19.38) and originating from Latin America or the Caribbean (OR 6.59, CI 2.08;20.92). Smaller, yet significant risk factors for VF were being infected through a blood transfusion or a needle accident (OR9.93, CI 1.34;73.84, and having started with cART with a nadir CD4 count >500 cells/μl (OR 11.36, CI 2.03;63.48).In our large cohort of young adults, the risk of VF has diminished over 15 years. Specific subgroups were identified to be at risk for suboptimal treatment.

Identifiants

pubmed: 31393344
doi: 10.1097/MD.0000000000016357
pii: 00005792-201908090-00004
pmc: PMC6709178
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16357

Références

AIDS Behav. 2013 Jan;17(1):213-23
pubmed: 22041930
Lancet Public Health. 2016 Nov;1(1):e26-e36
pubmed: 28299369
AIDS. 2014 Aug 24;28(13):1945-56
pubmed: 24845154
AIDS Behav. 2013 Jan;17(1):86-93
pubmed: 23142855
PLoS One. 2016 Apr 01;11(4):e0151106
pubmed: 27035905
AIDS Patient Care STDS. 2015 Feb;29(2):77-85
pubmed: 25682888
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19393
pubmed: 25724503
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):193-7
pubmed: 21826014
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
BMC Med. 2014 Aug 21;12:142
pubmed: 25145556
HIV Med. 2018 Jan;19(1):42-48
pubmed: 28741837
Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70
pubmed: 16061785
AIDS Patient Care STDS. 2015 Jun;29(6):354-64
pubmed: 25825814
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):169-77
pubmed: 25590270
Clin Infect Dis. 2011 Jan 15;52 Suppl 2:S214-22
pubmed: 21342910
Drugs Aging. 2013 Oct;30(10):809-19
pubmed: 23959913
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
pubmed: 10817843
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e1-e6
pubmed: 28489729
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9
pubmed: 25559604
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):446-453
pubmed: 27391389
J Int AIDS Soc. 2017 Nov;20(3):
pubmed: 29130644
BMJ Open. 2018 Sep 24;8(9):e022516
pubmed: 30249631
Cochrane Database Syst Rev. 2013 Jun 05;(6):CD008270
pubmed: 23740608
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):110-117
pubmed: 28991884
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4
pubmed: 12489844
AIDS Patient Care STDS. 2014 Mar;28(3):128-35
pubmed: 24601734
MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):969-974
pubmed: 28934185
AIDS Care. 2016 Sep;28(9):1166-70
pubmed: 27011102
AIDS Patient Care STDS. 2017 Sep;31(9):377-383
pubmed: 28891717

Auteurs

Annouschka M Weijsenfeld (AM)

Department of Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam.
Department of Internal Medicine, Amsterdam UMC, University of Amsterdam.

Charlotte Blokhuis (C)

Department of Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam.

Martijn M Stuiver (MM)

Department of Clinical Epidemiology Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam.

Ferdinand W N M Wit (FWNM)

Department of Internal Medicine, Amsterdam UMC, University of Amsterdam.
HIV Monitoring Foundation (Stichting Hiv Monitoring), Amsterdam, the Netherlands.

Dasja Pajkrt (D)

Department of Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH